| Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer … S Toback, E Galiza, C Cosgrove, J Galloway, AL Goodman, PA Swift, ... The Lancet Respiratory Medicine 10 (2), 167-179, 2022 | 135 | 2022 |
| Stratified primary care versus non-stratified care for musculoskeletal pain: findings from the STarT MSK feasibility and pilot cluster randomized controlled trial JC Hill, S Garvin, Y Chen, V Cooper, S Wathall, B Saunders, M Lewis, ... BMC family practice 21, 1-18, 2020 | 65 | 2020 |
| Factors that impact on immediate graft function in patients after renal transplantation J Sieńko, M Wisniewska, M Ostrowski, K Ciechanowski, K Safranow, ... Transplantation proceedings 35 (6), 2153-2154, 2003 | 30 | 2003 |
| Risk-based stratified primary care for common musculoskeletal pain presentations (STarT MSK): a cluster-randomised, controlled trial JC Hill, S Garvin, K Bromley, B Saunders, J Kigozi, V Cooper, M Lewis, ... The Lancet Rheumatology 4 (9), e591-e602, 2022 | 29 | 2022 |
| Stratified primary care versus non-stratified care for musculoskeletal pain: qualitative findings from the STarT MSK feasibility and pilot cluster randomized controlled trial B Saunders, JC Hill, NE Foster, V Cooper, J Protheroe, A Chudyk, ... BMC Family Practice 21, 1-12, 2020 | 20 | 2020 |
| Computer-based stratified primary care for musculoskeletal consultations compared with usual care: study protocol for the STarT MSK cluster randomized controlled trial J Hill, S Garvin, Y Chen, V Cooper, S Wathall, B Bartlam, B Saunders, ... JMIR research protocols 9 (7), e17939, 2020 | 15 | 2020 |
| Impact of selected factors on early graft function in patients after renal transplantation J Sienko, M Wisniewska, M Ostrowski, K Ciechanowski, K Safranow, ... Transplantation proceedings 35 (6), 2167-2169, 2003 | 13 | 2003 |
| Risk-based stratified primary care for common musculoskeletal pain presentations: qualitative findings from the STarT MSK cluster randomised controlled trial B Saunders, A Chudyk, J Protheroe, V Cooper, B Bartlam, H Birkinshaw, ... BMC Primary Care 23 (1), 326, 2022 | 6 | 2022 |
| Programme grants for applied research H Hemingway, GS Feder, NK Fitzpatrick, S Denaxas, AD Shah, ... Using Nationwide ‘Big Data’from Linked Electronic Health Records to Help …, 0 | 5 | |
| Soluble HLA class I molecules exert differentiated influence on renal graft condition A Chudyk, M Masiuk, M Myślak, L Domański, J Sieńko, T Sulikowski, ... Transplantation proceedings 38 (1), 90-93, 2006 | 4 | 2006 |
| Integrating clinician support with intervention design as part of a programme testing stratified care for musculoskeletal pain in general practice J Protheroe, B Saunders, JC Hill, A Chudyk, NE Foster, B Bartlam, ... BMC Family Practice 22, 1-14, 2021 | 3 | 2021 |
| Testing Stratified Care for Musculoskeletal Pain in General Practice: Integrating Clinician Support and Intervention Design J Protheroe, B Saunders, JC Hill, A Chudyk, NE Foster, B Bartlam, ... | 2 | 2021 |
| Stratified care for patients with back, neck, knee, shoulder or multi-site pain: the STarT MSK Feasibility/Pilot Randomised Controlled Trial (Isrctn15366334) J Hill, B Saunders, B Bartlam, M Lewis, Y Chen, S Wathall, A Chudyk, ... Physiotherapy 107, e58-e59, 2020 | 1 | 2020 |
| 767 EXPLORING THE POTENTIAL EXTENDED ROLE OF COMMUNITY PHARMACY IN THE MANAGEMENT OF OSTEOARTHRITIS: SURVEYS AND INTERVIEWS WITH COMMUNITY PHARMACY STAFF AND OTHER HEALTHCARE … J Simkins, M Holden, OO Babatunde, S White, E Nicholls, A Long, ... Elsevier, 2024 | | 2024 |
| 768 STAKEHOLDER CO-DESIGN OF AN EXTENDED COMMUNITY PHARMACY ROLE AND SERVICE DELIVERY MODEL FOR PROVIDING OSTEOARTHRITS CARE: THE PHARMOA MODEL M Holden, C Stanford, J Simkins, OO Babatunde, S White, N O'Brien, ... Elsevier, 2024 | | 2024 |
| Cost-utility analysis of risk-based stratified primary care for common musculoskeletal pain presentations: a cluster-randomised, controlled trial J Kigozi, JC Hill, K Bromley, M Lewis, S Wathall, A Chudyk, KM Dunn, ... | | 2024 |
| STAKEHOLDER CO-DESIGN OF AN EXTENDED COMMUNITY PHARMACY ROLE AND SERVICE DELIVERY MODEL FOR PROVIDING OSTEOARTHRITS CARE: THE PHARMOA MODEL M Holden, C Stanford, J Simkins, OO Babatunde, S White, N O'Brien, ... Osteoarthritis and Cartilage 32, S526, 2024 | | 2024 |
| EXPLORING THE POTENTIAL EXTENDED ROLE OF COMMUNITY PHARMACY IN THE MANAGEMENT OF OSTEOARTHRITIS: SURVEYS AND INTERVIEWS WITH COMMUNITY PHARMACY STAFF AND OTHER HEALTHCARE … J Simkins, M Holden, OO Babatunde, S White, E Nicholls, A Long, ... Osteoarthritis and Cartilage 32, S525-S526, 2024 | | 2024 |
| The SelfSTarT intervention for low back pain patients presenting to first contact physiotherapists: A mixed methods service evaluation K Stevenson, T Hadley‐Barrows, N Evans, L Campbell, J Southam, ... Musculoskeletal Care 22 (1), e1876, 2024 | | 2024 |
| Exploring the potential extended role of community pharmacy in the management of osteoarthritis: A multi‐methods study with pharmacy staff and other healthcare professionals J Simkins, MA Holden, O Babatunde, S White, E Nicholls, A Long, ... Musculoskeletal Care 22 (1), e1873, 2024 | | 2024 |
